Kyung-Suk Suh Selected Research

Hepatitis B Surface Antigens (HBsAg)

1/2023	Hepatitis B immunoglobulin inhibits the secretion of HBV via antigen-antibody precipitation in the multivesicular body.
5/2016	Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence.
5/2015	Comparison of transarterial chemoembolization and hepatic resection for large solitary hepatocellular carcinoma: a propensity score analysis.
12/2013	Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors.
6/2006	Change of hepatitis B virus DNA status in anti-HBc positive liver graft.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung-Suk Suh Research Topics

Disease

95	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 09/2004
57	Neoplasms (Cancer) 02/2023 - 12/2004
13	Hepatitis B 04/2023 - 06/2003
10	Pathologic Constriction (Stenosis) 02/2024 - 12/2007
10	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 08/2010
10	Infections 04/2023 - 06/2003
10	Neoplasm Metastasis (Metastasis) 03/2023 - 05/2010
9	Thrombosis (Thrombus) 01/2023 - 12/2007
7	End Stage Liver Disease 04/2024 - 01/2007
6	Fibrosis (Cirrhosis) 01/2023 - 01/2008
6	Liver Diseases (Liver Disease) 09/2020 - 06/2006
5	Cholangiocarcinoma 05/2022 - 12/2002
4	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2022 - 05/2006
4	Hemorrhage 07/2021 - 11/2003
4	Liver Failure 04/2021 - 02/2016
3	Acute Liver Failure (Fulminant Hepatic Failure) 04/2024 - 06/2005
3	Ascites 01/2024 - 03/2014
3	Kidney Diseases (Kidney Disease) 09/2023 - 08/2010
3	Hepatorenal Syndrome 01/2023 - 08/2010
3	Biliary Atresia 12/2022 - 12/2014
3	Wounds and Injuries (Trauma) 01/2022 - 09/2011
3	Portal Hypertension 01/2021 - 05/2015
3	Varicose Veins (Varicose Vein) 01/2021 - 07/2008
3	Non-alcoholic Fatty Liver Disease 01/2020 - 05/2014
3	Carcinogenesis 11/2019 - 05/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2013 - 10/2007
2	Flatulence 01/2024 - 11/2016
2	Fatty Liver 09/2023 - 05/2010
2	Inflammation (Inflammations) 01/2023 - 11/2015
2	Pain (Aches) 10/2022 - 10/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 06/2017
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 03/2014
2	Reperfusion Injury 01/2022 - 10/2019
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 11/2021
2	Exanthema (Rash) 11/2021 - 10/2007
2	Emergence Delirium 06/2021 - 01/2020
2	Splenomegaly 01/2021 - 07/2008
2	Delirium 01/2020 - 01/2013
2	Liver Neoplasms (Liver Cancer) 11/2019 - 01/2018
2	Hyponatremia 12/2018 - 01/2013
2	Hepatitis C 12/2017 - 09/2016
2	Budd-Chiari Syndrome (Budd Chiari Syndrome) 11/2016 - 09/2015
2	Intrahepatic Cholestasis 03/2014 - 10/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2010 - 04/2004
2	Body Weight (Weight, Body) 08/2008 - 06/2006
1	Incisional Hernia 02/2024

Drug/Important Bio-Agent (IBA)

17	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2021 - 10/2005
8	Immunoglobulins (Immunoglobulin)IBA 04/2023 - 03/2007
8	Proteins (Proteins, Gene)FDA Link 03/2023 - 10/2015
7	Sorafenib (BAY 43-9006)FDA Link 03/2023 - 01/2017
5	acarboxyprothrombin (PIVKA)IBA 03/2023 - 06/2014
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 06/2006
5	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2015
5	Tacrolimus (Prograf)FDA LinkGeneric 09/2020 - 06/2006
5	Fetal Proteins (Fetoprotein)IBA 11/2018 - 08/2013
4	Vitamin K FDA Link 03/2023 - 06/2014
4	hepatitis B hyperimmune globulinIBA 01/2023 - 06/2003
4	Immunosuppressive Agents (Immunosuppressants)IBA 09/2022 - 06/2014
4	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 02/2009
3	Antiviral Agents (Antivirals)IBA 04/2023 - 12/2013
3	gadolinium ethoxybenzyl DTPA FDA Link 01/2023 - 08/2015
3	Sirolimus (Rapamycin)FDA Link 09/2022 - 05/2016
3	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
3	SodiumIBA 01/2021 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 09/2007
3	Keratin-19 (Keratin 19)IBA 06/2017 - 06/2012
3	Lamivudine (Epivir)FDA Link 09/2007 - 06/2003
2	TOR Serine-Threonine KinasesIBA 02/2024 - 01/2017
2	SolutionsIBA 01/2024 - 05/2006
2	AntigensIBA 01/2023 - 12/2015
2	Calcineurin InhibitorsIBA 09/2022 - 08/2010
2	Indicators and Reagents (Reagents)IBA 06/2021 - 10/2012
2	Dexmedetomidine FDA Link 06/2021 - 01/2020
2	Polytetrafluoroethylene (Teflon)FDA Link 04/2021 - 09/2011
2	Messenger RNA (mRNA)IBA 11/2019 - 10/2017
2	GlypicansIBA 08/2018 - 12/2015
2	Prothrombin (Factor II)IBA 01/2018 - 06/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2017 - 10/2012
2	Protein Disulfide-IsomerasesIBA 01/2017 - 09/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016 - 05/2009
2	VaccinesIBA 12/2015 - 06/2006
2	Ethanol (Ethyl Alcohol)IBA 08/2013 - 10/2007

Therapy/Procedure

134	Liver Transplantation 04/2024 - 06/2003
24	Hepatectomy 03/2023 - 09/2004
17	Transplantation 06/2023 - 06/2006
13	Therapeutics 01/2021 - 04/2004
9	Radiofrequency Ablation 11/2021 - 08/2013
7	Length of Stay 10/2022 - 03/2014
5	Contraindications 01/2021 - 08/2008
4	Drug Therapy (Chemotherapy) 10/2021 - 03/2007
4	Stents 01/2021 - 09/2015
3	Organ Transplantation 10/2023 - 01/2022
3	Operative Surgical Procedures 06/2021 - 04/2016
3	Thrombectomy 01/2021 - 12/2014
2	Artificial Respiration (Mechanical Ventilation) 04/2024 - 01/2020
2	Critical Care (Surgical Intensive Care) 01/2023 - 10/2022
2	Adjuvant Chemotherapy 05/2022 - 11/2011
2	Conservative Treatment 01/2017 - 11/2003
2	Ligation 01/2017 - 06/2005
2	Neoadjuvant Therapy 08/2015 - 11/2011